Crossmark

Combined targeting of G protein‐coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN‐null triple negative breast cancer

Crossref DOI link: https://doi.org/10.15252/emmm.202011987

Published Online: 2020-07-16

Published Print: 2020-08-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zecchin, Davide

Moore, Christopher

Michailidis, Fanourios

Horswell, Stuart

Rana, Sareena

Howell, Michael

Downward, Julian https://orcid.org/0000-0002-2331-4729
Funding

Funding for this research was provided by:

Cancer Research UK (FC001070)

UK Research and Innovation | Medical Research Council (FC001070)

Wellcome Trust (FC001070)

Wellcome Trust (103799/Z/14/Z)

EC |FP7 | FP7 Ideas: European Research Council
License Information

Text and Data Mining valid from 2020-07-16

Version of Record valid from 2020-07-16
More Information

Article History

Received: 6 January 2020

Revised: 9 June 2020

Accepted: 16 June 2020

First Online: 16 July 2020

Conflict of interest

: The authors report no conflicts of interest related to this work.

Document is current

Any future updates will be listed below